A recent paper demonstrated that ASXL1 mutations that cause Bohring–Opitz Syndrome (BOS) have a distinct methylation episignature from other chromatinopathy disorders, like Kabuki syndrome, Sotos syndrome, and Weaver syndrome (Awamleh et al. 2022). Here, ASXL1 is linked to Buschke-Ollendorff syndrome.